APA (7th ed.) Citation

Yuri Murayama, Hiromichi Hamada, Yuki Shiko, Yoshihiro Onouchi, Nobuyuki Kakimoto, Yoshihito Ozawa, . . . Hiroyuki Suzuki. (2023). Risk factors for coronary artery abnormalities and resistance to immunoglobulin plus ciclosporin A therapy in severe Kawasaki disease: Subanalysis of the KAICA trial, randomized trial for cicrosporin A as the first-line treatment. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Yuri Murayama, et al. Risk Factors for Coronary Artery Abnormalities and Resistance to Immunoglobulin Plus Ciclosporin A Therapy in Severe Kawasaki Disease: Subanalysis of the KAICA Trial, Randomized Trial for Cicrosporin A as the First-line Treatment. Frontiers Media S.A., 2023.

MLA (9th ed.) Citation

Yuri Murayama, et al. Risk Factors for Coronary Artery Abnormalities and Resistance to Immunoglobulin Plus Ciclosporin A Therapy in Severe Kawasaki Disease: Subanalysis of the KAICA Trial, Randomized Trial for Cicrosporin A as the First-line Treatment. Frontiers Media S.A., 2023.